Belite Bio (BLTE) Misses Q2 EPS by 26c
Tweet
Share
E-mailGet Alerts BLTE Hot Sheet
Join SI Premium – FREE
Belite Bio (NASDAQ: BLTE) reported Q2 EPS of ($0.26).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UnitedHealth Group (UNH) PT Raised to $468 at Morgan Stanley
- Definium Therapeutics Inc (DFTX) PT Lowered to $58 at Canaccord
- Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
